Consult with your surgeon and a qualified trainer or physiotherapist to devise a phased plan aligned with healing milestones and surgical recommendations
This combination of increased usage and expanded state coverage has increased Medicaid spending on GLP-1s for obesity to more than $500 million in October 2024 alone, with total expenditures reaching $3.5 billion over the past 12 months
Mental health issues: Contrave may increase anxiety, insomnia, irritability, and a very small risk of suicidal thoughts and behaviors
Slowing Gastric Emptying: By delaying the movement of food from the stomach to the small intestine, GLP-1 helps to flatten post-meal glucose spikes and promotes a feeling of fullness
Ro: Program features compared Both Noom and Ro provide access to GLP-1 medications for eligible people, but the programs differ in structure, guidance, and ongoing support
The shipping label must clearly state the contents are not for human consumption